Model
Edge
Lineage Cell Therapeutics
0001223697
Filing Type
4
Filing Date
2/7/2024
Updated
2/8/24, 12:00 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership